Clinical Experiment of Helicobacter Pylori Transmission - Full Text View

Clinical Experiment of Helicobacter Pylori Transmission

This study is ongoing, but not recruiting participants.

Sponsored by:	Stanford University
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00550368

Purpose

The study proposes to test whether chronic infection with Helicobacter pylori protects individuals from symptomatic infection with enteropathogenic E. coli. The study will also evaluate the effect of gastric acidity in this relationship.

Condition	Intervention
Infection Achlorhydria	Biological: Biological intervention: Enteropathogenic E. coli

MedlinePlus related topics:

Diarrhea

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study

Official Title:	Effect of Gastric Acid and H. Pylori Infection on Infection With Enteropathogenic E. Coli

Further study details as provided by Stanford University:

Primary Outcome Measures:

Development of diarrhea

Secondary Outcome Measures:

Intensity of diarrhea

Estimated Enrollment:	60
Study Start Date:	August 2005

Eligibility

Ages Eligible for Study:	35 Years to 59 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:Healthy Exclusion Criteria:prior gastrointestinal disease prior treatment of H. pylori infection immune suppression or deficiency history of cancer, diabetes, or other co-morbidity

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00550368

Locations


United States, California
	Stanford University School of Medicine
	Stanford, California, United States, 94305

Sponsors and Collaborators

Stanford University

Investigators


Principal Investigator:	Julie Parsonnet	Stanford University

More Information

Study ID Numbers:	688
First Received:	October 25, 2007
Last Updated:	June 16, 2008
ClinicalTrials.gov Identifier:	NCT00550368
Health Authority:	USA:Institutional Review Board

Study placed in the following topic categories:

Metabolic Diseases

Digestive System Diseases

Stomach Diseases

Gastrointestinal Diseases

Achlorhydria

Metabolic disorder

Additional relevant MeSH terms:

Communicable Diseases

Infection

Acid-Base Imbalance

ClinicalTrials.gov processed this record on August 29, 2008